Synaptic modulation by a Drosophila neuropeptide is motor neuron-specific and requires CaMKII activity

The Drosophila FMRFamide-related peptide, DPKQDFMRFamide modulates synaptic transmission at the larval neuromuscular junction. The amplitude of excitatory junctional potentials (EJPs) produced by the selective stimulation of motor neuron MN6/7-Ib increases following application of 1 microM DPKQDFMRFamide. EJPs elicited by stimulating motor neuron MNSNb/d-Is, however, exhibit no significant increase with the same concentration of neuropeptide. The mechanisms underlying the modulatory effects of DPKQDFMRFamide were examined using a combination of pharmacological and genetic methods. Three independent lines of evidence implicate CaMKII as an essential effector protein or part of the signal transduction pathway. The effect of the neuropeptide is suppressed by 1 microM KN-93 (CaMKII inhibitor) and by heat-shock induced expression of a CaMKII inhibitor. A heterozygous CaM kinase mutant responds poorly to the peptide.